vidarabine has been researched along with Muscular Dystrophy, Duchenne in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balasubramanian, A; Bambach, BJ; Bennett, RR; Darras, BT; Estrella, E; Gussoni, E; Kang, PB; Kunkel, LM; Kurtzberg, J; Lidov, HG; Mitchell, M; Shapiro, FD; White, AJ | 1 |
1 other study(ies) available for vidarabine and Muscular Dystrophy, Duchenne
Article | Year |
---|---|
Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Child; Chromosome Mapping; Chromosomes, Human, X; Cyclophosphamide; Dystrophin; Follow-Up Studies; Gene Deletion; Gene Expression Regulation; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Male; Muscular Dystrophy, Duchenne; Reoperation; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2010 |